Home/Filings/4/0001209191-13-006124
4//SEC Filing

Lee Dana 4

Accession 0001209191-13-006124

CIK 0000949699other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 5:39 PM ET

Size

5.5 KB

Accession

0001209191-13-006124

Insider Transaction Report

Form 4
Period: 2013-02-04
Lee Dana
VP, Clinical Drug Safety
Transactions
  • Award

    Stock Option (Right to Buy)

    2013-02-04+15,00015,000 total
    Exercise: $69.82From: 2013-02-04Exp: 2023-02-04Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The option vests 3/48 on April 11, 2013; the remainder vests proportionately on each of April 11, 2014, April 11, 2015, April 11, 2016 and April 11, 2017. The vesting of the options are subject to satisfaction of certain performance criteria.

Issuer

PHARMACYCLICS INC

CIK 0000949699

Entity typeother

Related Parties

1
  • filerCIK 0001568643

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:39 PM ET
Size
5.5 KB